Transform PK/PD workflows with automation and integration Blog 通过自动化与集成革新 PK/PD 工作流程 Reduce delays and errors in PK/PD workflows. See where workflows stall, from data prep to…Certara2026 年 1 月 14 日
Phoenix® PK/PD Software now Includes Generative AI pharmacokinetic (PK) Reports Announcement Phoenix® PK/PD 软件新增生成式 AI 药代动力学报告模块 New module transforms tables, figures and listings into draft PK reports saving scientists weeks of…Certara2026 年 1 月 12 日
Efficient creation of Tables, Figures & Listings with Certara’s Phoenix Cloud TFL Studio APAC Webinar On-Demand Webinar Efficient creation of Tables, Figures & Listings with Certara’s Phoenix Cloud TFL Studio APAC Webinar Watch our webinar with Kristin Follman to discover how TFL Studio streamlines the process to…Certara2026 年 1 月 5 日
Delivering on deadline: Why pharmacometrics (pmx) is the anchor of successful regulatory submissions Blog 按时交付:Why pharmacometrics (pmx) is the anchor of successful regulatory submissions Explore how PMx regulatory submissions, exposure-response modeling, and strategic pharmacometrics planning support successful and timely…Certara2025 年 12 月 29 日
Certara Announces New Release of Integral® Software Announcement Certara Announces New Release of Integral® Software Latest version enhances efficiency, compliance, and user experience for PK scientists Radnor, PA. — December…Danielle Pillsbury2025 年 12 月 16 日
Using M&S to evaluate oncology drug dosing Blog Using M&S to evaluate oncology drug dosing Learn how modeling & simulation improves oncology drug dosing, optimizing safety, efficacy, and personalized treatment…Certara2025 年 11 月 14 日
ACoP 2025 insights: Scaling the future of QSP modeling with Certara IQ™ Blog ACoP 2025 insights: Scaling the future of QSP modeling with Certara IQ™ At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…Certara2025 年 11 月 13 日
Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix® On-Demand Webinar Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix® Watch our on-demand webinar on empiric PK time-course scaling and learn how Certara’s translational experts…Certara2025 年 11 月 13 日
Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema Publication Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema Certara and Ionis analyzed Phase 3 OASIS-HAE data showing flexible, effective donidalorsen dosing can reduce…Certara2025 年 11 月 12 日